Hollsteen
← Applied Materials

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $7.2B · 10-Q 0000006951-16-000041 filed Feb 25, 2016Equity incl. NCI · Q2 FY2016: $6.6B · 10-Q 0000006951-16-000048 filed May 26, 2016Equity incl. NCI · Q3 FY2016: $6.8B · 10-Q 0000006951-16-000059 filed Aug 25, 2016Equity incl. NCI · Q4 FY2016: $7.4B · 10-K 0000006951-19-000046 filed Dec 13, 2019Equity incl. NCI · Q1 FY2017: $7.7B · 10-Q 0000006951-17-000007 filed Feb 23, 2017Equity incl. NCI · Q2 FY2017: $8.2B · 10-Q 0000006951-17-000015 filed May 25, 2017Equity incl. NCI · Q3 FY2017: $8.7B · 10-Q 0000006951-17-000026 filed Aug 24, 2017Equity incl. NCI · Q4 FY2017: $9.6B · 10-K 0000006951-19-000046 filed Dec 13, 2019Equity incl. NCI · Q1 FY2018: $8.8B · 10-Q 0000006951-19-000008 filed Feb 21, 2019Equity incl. NCI · Q2 FY2018: $7.3B · 10-Q 0000006951-19-000019 filed May 23, 2019Equity incl. NCI · Q3 FY2018: $7.0B · 10-Q 0000006951-19-000029 filed Aug 22, 2019Equity incl. NCI · Q4 FY2018: $6.8B · 10-K 0000006951-19-000046 filed Dec 13, 2019Equity incl. NCI · Q1 FY2019: $8.2B · 10-Q 0000006951-19-000008 filed Feb 21, 2019Equity incl. NCI · Q2 FY2019: $8.2B · 10-Q 0000006951-19-000019 filed May 23, 2019Equity incl. NCI · Q3 FY2019: $8.1B · 10-Q 0000006951-19-000029 filed Aug 22, 2019Equity incl. NCI · Q4 FY2019: $8.2B · 10-K 0000006951-19-000046 filed Dec 13, 2019Equity incl. NCI · Q1 FY2020: $8.7B · 10-Q 0000006951-20-000014 filed Feb 20, 2020Equity incl. NCI · Q2 FY2020: $9.0B · 10-Q 0000006951-20-000028 filed May 21, 2020Equity incl. NCI · Q3 FY2020: $9.6B · 10-Q 0000006951-20-000037 filed Aug 20, 2020Equity incl. NCI · Q4 FY2020: $10.6B · 10-K 0000006951-20-000048 filed Dec 11, 2020Equity incl. NCI · Q1 FY2021: $11.5B · 10-Q 0000006951-21-000013 filed Feb 25, 2021Equity incl. NCI · Q2 FY2021: $12.0B · 10-Q 0000006951-21-000023 filed May 27, 2021Equity incl. NCI · Q3 FY2021: $12.1B · 10-Q 0000006951-21-000034 filed Aug 26, 2021Equity incl. NCI · Q4 FY2021: $12.2B · 10-K 0000006951-21-000043 filed Dec 17, 2021Equity incl. NCI · Q1 FY2022: $11.9B · 10-Q 0000006951-22-000011 filed Feb 24, 2022Equity incl. NCI · Q2 FY2022: $11.6B · 10-Q 0000006951-22-000022 filed May 26, 2022Equity incl. NCI · Q3 FY2022: $12.1B · 10-Q 0000006951-22-000032 filed Aug 25, 2022Equity incl. NCI · Q4 FY2022: $12.2B · 10-K 0000006951-22-000043 filed Dec 16, 2022Equity incl. NCI · Q1 FY2023: $13.4B · 10-Q 0000006951-23-000012 filed Feb 23, 2023Equity incl. NCI · Q2 FY2023: $14.1B · 10-Q 0000006951-23-000022 filed May 26, 2023Equity incl. NCI · Q3 FY2023: $15.1B · 10-Q 0000006951-23-000031 filed Aug 24, 2023Equity incl. NCI · Q4 FY2023: $16.3B · 10-K 0000006951-23-000041 filed Dec 15, 2023Equity incl. NCI · Q1 FY2024: $17.4B · 10-Q 0000006951-24-000012 filed Feb 27, 2024Equity incl. NCI · Q2 FY2024: $18.2B · 10-Q 0000006951-24-000022 filed May 23, 2024Equity incl. NCI · Q3 FY2024: $18.8B · 10-Q 0000006951-24-000032 filed Aug 22, 2024Equity incl. NCI · Q4 FY2024: $19.0B · 10-K 0000006951-24-000044 filed Dec 13, 2024Equity incl. NCI · Q1 FY2025: $18.6B · 10-Q 0000006951-25-000011 filed Feb 20, 2025Equity incl. NCI · Q2 FY2025: $19.0B · 10-Q 0000006951-25-000024 filed May 22, 2025Equity incl. NCI · Q3 FY2025: $19.5B · 10-Q 0000006951-25-000037 filed Aug 21, 2025Equity incl. NCI · Q4 FY2025: $20.4B · 10-K 0001628280-25-056742 filed Dec 12, 2025Equity incl. NCI · Q1 FY2026: $21.7B · 10-Q 0001628280-26-009694 filed Feb 19, 2026Equity incl. NCI · Q2 FY2026: $23.9B · 10-Q 0001628280-26-037227 filed May 21, 2026Equity incl. NCI · Q3 FY2026: $25.6B · 10-Q 0001628280-26-058235 filed Aug 20, 20267.225.6Q1 FY2016Q3 FY2026Q2 FY2021
$BEquity incl. NCI · Q1 FY2016: $7.2B · 10-Q 0000006951-16-000041 filed Feb 25, 2016Equity incl. NCI · Q2 FY2016: $6.6B · 10-Q 0000006951-16-000048 filed May 26, 2016Equity incl. NCI · Q3 FY2016: $6.8B · 10-Q 0000006951-16-000059 filed Aug 25, 2016Equity incl. NCI · Q4 FY2016: $7.4B · 10-K 0000006951-19-000046 filed Dec 13, 2019Equity incl. NCI · Q1 FY2017: $7.7B · 10-Q 0000006951-17-000007 filed Feb 23, 2017Equity incl. NCI · Q2 FY2017: $8.2B · 10-Q 0000006951-17-000015 filed May 25, 2017Equity incl. NCI · Q3 FY2017: $8.7B · 10-Q 0000006951-17-000026 filed Aug 24, 2017Equity incl. NCI · Q4 FY2017: $9.6B · 10-K 0000006951-19-000046 filed Dec 13, 20197.29.6Q1 FY2016Q4 FY2017Q1 FY2017
Q1 FY2016
7.2$B
All values (43)
PeriodValue ($B)Status
Q3 FY202625.6reported
Q2 FY202623.9reported
Q1 FY202621.7reported
Q4 FY202520.4reported
Q3 FY202519.5reported
Q2 FY202519.0reported
Q1 FY202518.6reported
Q4 FY202419.0reported
Q3 FY202418.8reported
Q2 FY202418.2reported
Q1 FY202417.4reported
Q4 FY202316.3reported
Q3 FY202315.1reported
Q2 FY202314.1reported
Q1 FY202313.4reported
Q4 FY202212.2reported
Q3 FY202212.1reported
Q2 FY202211.6reported
Q1 FY202211.9reported
Q4 FY202112.2reported
Q3 FY202112.1reported
Q2 FY202112.0reported
Q1 FY202111.5reported
Q4 FY202010.6reported
Q3 FY20209.6reported
Q2 FY20209.0reported
Q1 FY20208.7reported
Q4 FY20198.2reported
Q3 FY20198.1reported
Q2 FY20198.2reported
Q1 FY20198.2reported
Q4 FY20186.8reported
Q3 FY20187.0reported
Q2 FY20187.3reported
Q1 FY20188.8reported
Q4 FY20179.6reported
Q3 FY20178.7reported
Q2 FY20178.2reported
Q1 FY20177.7reported
Q4 FY20167.4reported
Q3 FY20166.8reported
Q2 FY20166.6reported
Q1 FY20167.2reported

CSV with all sources · Technical ID: equity_total

More metrics for Applied Materials

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$7.2B
Period
Q1 FY2016, ended Jan 31, 2016 · as of Jan 31, 2016 (balance as of date, not a sum)
Source
10-Q, filed Feb 25, 2016 · 0000006951-16-000041
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$7.2BFeb 25, 201610-Q 0000006951-16-000041reported · confidence 1. · current